C Webber1, M Whitehead2, A Eisen3, C M B Holloway3,4, P A Groome2,5. 1. The Ottawa Hospital Research Institute and Bruyère Research Institute, Ottawa. 2. ices Queen's, Kingston. 3. Ontario Health (Cancer Care Ontario), Toronto. 4. Department of Surgery, University of Toronto, Toronto. 5. Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, and Department of Public Health Sciences, Queen's University, Kingston, ON.
Abstract
Background: Breast assessment sites (bass) were developed to provide expedited and coordinated care for patients being evaluated for breast cancer (bca) in Ontario. We compared the diagnostic and treatment intervals for patients diagnosed at a bas and for those diagnosed through a usual care (uc) route. Methods: This population-based, cross-sectional study of patients diagnosed with bca in Ontario during 2007-2015 used linked administrative data. "Diagnostic interval" was the time from the earliest cancer-related health care encounter before diagnosis to diagnosis; "treatment interval" was the time from diagnosis to treatment. Diagnosis at a bas was determined from the patient's biopsy and mammography institutions. Interval lengths for the bas and uc groups were compared using multivariable quantile regression, stratified by detection method. Results: The diagnostic interval was shorter for patients who were bas-diagnosed than for those who were uc-diagnosed, with adjusted median differences of -4.0 days [95% confidence interval (ci): -3.2 days to -4.9 days] for symptomatic patients and -5.4 days (95% ci: -4.7 days to -6.1 days) for screen-detected patients. That association was modified by stage at diagnosis, with larger differences in patients with early-stage cancers. In contrast, the treatment interval was longer in patients who were bas-diagnosed than in those who were uc-diagnosed, with adjusted median differences of 4.2 days (95% ci: 3.8 days to 4.7 days) for symptomatic patients and 4.2 days (95% ci: 3.7 days to 4.8 days) for screen-detected patients. Conclusions: Diagnosis of bca through a bas was associated with a shorter diagnostic interval, but a longer treatment interval. Although efficiencies in the diagnostic interval might help to reduce distress experienced by patients, the longer treatment intervals for patients who are bas-diagnosed remain a cause for concern. 2020 Multimed Inc.
Background: Breast assessment sites (bass) were developed to provide expedited and coordinated care for patients being evaluated for breast cancer (bca) in Ontario. We compared the diagnostic and treatment intervals for patients diagnosed at a bas and for those diagnosed through a usual care (uc) route. Methods: This population-based, cross-sectional study of patients diagnosed with bca in Ontario during 2007-2015 used linked administrative data. "Diagnostic interval" was the time from the earliest cancer-related health care encounter before diagnosis to diagnosis; "treatment interval" was the time from diagnosis to treatment. Diagnosis at a bas was determined from the patient's biopsy and mammography institutions. Interval lengths for the bas and uc groups were compared using multivariable quantile regression, stratified by detection method. Results: The diagnostic interval was shorter for patients who were bas-diagnosed than for those who were uc-diagnosed, with adjusted median differences of -4.0 days [95% confidence interval (ci): -3.2 days to -4.9 days] for symptomatic patients and -5.4 days (95% ci: -4.7 days to -6.1 days) for screen-detected patients. That association was modified by stage at diagnosis, with larger differences in patients with early-stage cancers. In contrast, the treatment interval was longer in patients who were bas-diagnosed than in those who were uc-diagnosed, with adjusted median differences of 4.2 days (95% ci: 3.8 days to 4.7 days) for symptomatic patients and 4.2 days (95% ci: 3.7 days to 4.8 days) for screen-detected patients. Conclusions: Diagnosis of bca through a bas was associated with a shorter diagnostic interval, but a longer treatment interval. Although efficiencies in the diagnostic interval might help to reduce distress experienced by patients, the longer treatment intervals for patients who are bas-diagnosed remain a cause for concern. 2020 Multimed Inc.
Entities:
Keywords:
Breast neoplasms; diagnostic interval; early detection; organized breast assessment; treatment interval
Authors: John Butler; Catherine Foot; Martine Bomb; Sara Hiom; Michel Coleman; Heather Bryant; Peter Vedsted; Jane Hanson; Mike Richards Journal: Health Policy Date: 2013-05-18 Impact factor: 2.980
Authors: Li Jiang; Julie Gilbert; Hugh Langley; Rahim Moineddin; Patti A Groome Journal: Eur J Cancer Care (Engl) Date: 2018-06-05 Impact factor: 2.520
Authors: Li Jiang; Julie Gilbert; Hugh Langley; Rahim Moineddin; Patti A Groome Journal: Health Promot Chronic Dis Prev Can Date: 2018-10 Impact factor: 3.240
Authors: Elaine C McKevitt; Carol K Dingee; Sher-Ping Leung; Carl J Brown; Nancy Y Van Laeken; Richard Lee; Urve Kuusk Journal: Cureus Date: 2017-12-07
Authors: David Weller; Peter Vedsted; Chantelle Anandan; Alina Zalounina; Evangelia Ourania Fourkala; Rakshit Desai; William Liston; Henry Jensen; Andriana Barisic; Anna Gavin; Eva Grunfeld; Mats Lambe; Rebecca-Jane Law; Martin Malmberg; Richard D Neal; Jatinderpal Kalsi; Donna Turner; Victoria White; Martine Bomb; Usha Menon Journal: BMJ Open Date: 2016-07-25 Impact factor: 2.692
Authors: Steven Habbous; Esha Homenauth; Andriana Barisic; Sharmilaa Kandasamy; Vicky Majpruz; Katharina Forster; Marta Yurcan; Anna M Chiarelli; Patti Groome; Claire M B Holloway; Andrea Eisen Journal: CMAJ Open Date: 2022-04-05